MeSH Review:
Schizophrenia
- Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders. Tanaka, S., Matsunaga, H., Kimura, M., Tatsumi, K., Hidaka, Y., Takano, T., Uema, T., Takeda, M., Amino, N. J. Neuroimmunol. (2003)
- Multivariate modelling and the Defence Mechanism Test: a comparative study of defensive structures in borderline, other personality disorders and schizophrenic disorder. Sundbom, E., Kullgren, G. Acta psychiatrica Scandinavica. (1992)
- Abnormal phosphatidylinositol-cycle of platelet membrane in schizophrenia--a preliminary study. Kaiya, H., Takeuchi, K., Namba, M., Imai, A., Nakashima, S., Nozawa, Y. Folia psychiatrica et neurologica japonica. (1984)
- Use of the Booklet Category Test to assess abstract concept formation in schizophrenic disorders. Steindl, S.R., Boyle, G.J. Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists. (1995)
- Experiences of a psychiatric outpatient team in Nicaragua. Mental health problems seen in a primary care setting. Penayo, U. Social psychiatry and psychiatric epidemiology. (1989)
- Costs and benefits of two doses of fluphenazine. Marder, S.R., Van Putten, T., Mintz, J., McKenzie, J., Lebell, M., Faltico, G., May, P.R. Arch. Gen. Psychiatry (1984)
- Dopaminergic mechanisms in the pathogenesis of schizophrenia. Goldstein, M., Deutch, A.Y. FASEB J. (1992)
- Backward-masking deficit in adolescents with schizophrenic disorders or attention deficit hyperactivity disorder. Rund, B.R., Oie, M., Sundet, K. The American journal of psychiatry. (1996)
- Physostigmine and lithium response in the schizophrenias. Edelstein, P., Schultz, J.R., Hirschowitz, J., Kanter, D.R., Garver, D.L. The American journal of psychiatry. (1981)
- Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Schwab, S.G., Hoefgen, B., Hanses, C., Hassenbach, M.B., Albus, M., Lerer, B., Trixler, M., Maier, W., Wildenauer, D.B. Biol. Psychiatry (2005)
- Dexamethasone suppression test and noradrenergic function in affective and schizophrenic disorders. Sora, I., Nishimon, K., Otsuki, S. Biol. Psychiatry (1986)
- Plasma prostaglandin E2 metabolite--measured as 11-deoxy-15-keto-13,14-dihydro-11 beta,16 xi-cyclo-PGE2--in twins with schizophrenic disorder. Mathé, A.A., Eberhard, G., Sääf, J., Wetterberg, L. Biol. Psychiatry (1986)
- Hyperasparaginemia in a schizophrenic patient. Perry, T.L., Wright, J.M., Hansen, S. Biol. Psychiatry (1983)
- Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients. Hesslinger, B., Normann, C., Langosch, J.M., Klose, P., Berger, M., Walden, J. Journal of clinical psychopharmacology. (1999)
- The use of benzodiazepines in the treatment of manic-depressive illness. Chouinard, G. The Journal of clinical psychiatry. (1988)
- Association between tryptophan hydroxylase gene polymorphism (A218C) and schizophrenic disorders. Hong, C.J., Tsai, S.J., Wang, Y.C. Schizophr. Res. (2001)
- Association for serotonin transporter gene variable number tandem repeat polymorphism and schizophrenic disorders. Tsai, S.J., Ouyang, W.C., Hong, C.J. Neuropsychobiology (2002)
- Association study of onset age, attempted suicide, aggressive behavior, and schizophrenia with a serotonin 1B receptor (A-161T) genetic polymorphism. Hong, C.J., Pan, G.M., Tsai, S.J. Neuropsychobiology (2004)
- Psychiatric aspects of epilepsy. Stevens, J.R. The Journal of clinical psychiatry. (1988)
- Dysfunction of protein kinase FA/GSK-3 alpha in lymphocytes of patients with schizophrenic disorder. Yang, S.D., Yu, J.S., Lee, T.T., Yang, C.C., Ni, M.H., Yang, Y.Y. J. Cell. Biochem. (1995)
- CYP1A2 activity is an important determinant of clozapine dosage in schizophrenic patients. Doude van Troostwijk, L.J., Koopmans, R.P., Vermeulen, H.D., Guchelaar, H.J. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. (2003)
- Apolipoprotein E genotype in Korean schizophrenic patients. Lee, M.K., Park, A.J., Nam, B.Y., Min, K.J., Kee, B.S., Park, D.B. J. Korean Med. Sci. (2001)
- Genetic markers for schizophrenic subgroups. Lange, V. Psychiatria clinica. (1982)
- Attentional disturbances in patients with unipolar psychotic depression: a selective and sustained attention study. Politis, A., Lykouras, L., Mourtzouchou, P., Christodoulou, G.N. Comprehensive psychiatry. (2004)